Clinical Trial Update: Transcriptional Framework for the Molecular Diagnosis of Response to Immunotherapy in Lung Cancer With Agnostic Potential

View source ↗

Summary

This clinical trial update describes a transcriptional framework intended to molecularly diagnose response to immunotherapy in non-small cell lung cancer, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Regina Elena Cancer Institute | Conditions: NSCLC | Status: RECRUITING